[Treatment of wrinkles with botulinum toxin].
Abstract
The use of botulinum toxin A for the treatment of wrinkles is increasing. Botulinum toxin A inhibits exocytosis of acetylcholine from 3 to 12 months, depending on the target tissue. Low-dose botulinum toxin A is used to smooth hyperkinetic facial lines. This is especially successful in the upper facial parts, since the target muscles (procerus, corrugator supracilii, frontalis, orbicularis oculi) all directly overlie the osseous structures of the face. This is not the case for the lower facial parts, and more side effects are encountered when treating, for example, wrinkles around the mouth. Contraindications to the use of botulinum toxin A are diseases affecting neuromuscular signal transduction, allergic reactions to components of the solution, therapy with aminoglycosides or acetylsalicylic acid prior to treatment, infections in the planned treatment area, and pregnancy and lactation. Alternative and complementary treatments include erbium-YAG or CO2 laser, as well as augmentation and surgical plastic procedures.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 5 | |
| 시술 | co2 laser
|
레이저 박피술 | dict | 1 | |
| 해부 | smooth
|
scispacy | 1 | ||
| 해부 | facial lines
|
scispacy | 1 | ||
| 해부 | upper facial
|
scispacy | 1 | ||
| 해부 | muscles
|
scispacy | 1 | ||
| 해부 | procerus
|
scispacy | 1 | ||
| 해부 | frontalis
|
scispacy | 1 | ||
| 해부 | orbicularis oculi
|
scispacy | 1 | ||
| 해부 | acetylcholine
|
scispacy | 1 | ||
| 해부 | tissue
|
scispacy | 1 | ||
| 합병증 | osseous structures
|
scispacy | 1 | ||
| 합병증 | neuromuscular signal
|
scispacy | 1 | ||
| 합병증 | wrinkles
|
scispacy | 1 | ||
| 약물 | botulinum toxin A
|
C0006050
botulinum toxin type A
|
scispacy | 1 | |
| 약물 | acetylcholine
|
C0001041
acetylcholine
|
scispacy | 1 | |
| 약물 | Low-dose
|
C1708745
Low-Dose Treatment
|
scispacy | 1 | |
| 약물 | aminoglycosides
|
C0002556
Aminoglycosides
|
scispacy | 1 | |
| 약물 | acetylsalicylic acid
|
C0004057
aspirin
|
scispacy | 1 | |
| 약물 | CO2
|
C0007012
carbon dioxide
|
scispacy | 1 | |
| 약물 | Low-dose botulinum toxin A
|
scispacy | 1 | ||
| 질환 | hyperkinetic
|
C0233574
Hyperkinetic
|
scispacy | 1 | |
| 질환 | diseases affecting neuromuscular signal transduction,
|
scispacy | 1 | ||
| 질환 | allergic reactions
|
C0020517
Hypersensitivity
|
scispacy | 1 | |
| 질환 | infections
|
C0851162
Infections of musculoskeletal system
|
scispacy | 1 | |
| 질환 | wrinkles
|
scispacy | 1 | ||
| 기타 | corrugator
|
scispacy | 1 | ||
| 기타 | botulinum toxin A
|
scispacy | 1 |
MeSH Terms
Adult; Animals; Botulinum Toxins, Type A; Combined Modality Therapy; Contraindications; Esthetics; Face; Facial Muscles; Female; Haplorhini; Humans; Injections, Intramuscular; Lactation; Laser Therapy; Lethal Dose 50; Middle Aged; Neuromuscular Agents; Posture; Pregnancy; Rhytidoplasty; Skin Aging; Surgery, Plastic; Time Factors; Treatment Outcome
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.